Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Blood Reviews
|
August 21, 2022
CHIPing away the progression potential of CHIP: A new reality in the making
Zhuoer Xie, Amer M Zeidan
Haematologica
|
June 15, 2023
Are <i>DDX41</i> variants of unknown significance and pathogenic variants created equal?
Zhuoer Xie, Daniel T Starczynowski
NEJM Evidence
|
February 6, 2024
How Great Is the Threat of Clonal Hematopoiesis? Let This New Risk Score Be Your Guide
Zhuoer Xie, Amy E DeZern
Hematology. American Society of Hematology. Education Program
|
December 9, 2023
Frontline treatment options for higher-risk MDS: can we move past azacitidine?
David A Sallman, Zhuoer Xie
Stress Biology
|
March 30, 2025
One stone for multiple birds: PigmR integrates multiple defense pathways for high and broad-spectrum blast resistance in rice
Zhuoer Xie, Leiyun Yang, Zhengguang Zhang
Leukemia Research
|
January 29, 2022
Clonal hematopoiesis: Molecular and clinical implications
Yael Kusne, Zhuoer Xie, Mrinal M Patnaik
Clinical Hematology International
|
December 27, 2022
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Carmelo Gurnari, Zhuoer Xie, Amer M Zeidan
Expert Review of Hematology
|
January 31, 2023
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia
Sangeetha Venugopal, Zhuoer Xie, Amer M Zeidan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2026
Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies
Rawan G Faramand, Zhuoer Xie, Michael D Jain
Cancer Journal (Sudbury, Mass.)
|
May 17, 2023
Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment
Jan Philipp Bewersdorf, Zhuoer Xie, Amer M Zeidan
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Blood Reviews
|
August 21, 2022
CHIPing away the progression potential of CHIP: A new reality in the making
Zhuoer Xie, Amer M Zeidan
Haematologica
|
June 15, 2023
Are <i>DDX41</i> variants of unknown significance and pathogenic variants created equal?
Zhuoer Xie, Daniel T Starczynowski
NEJM Evidence
|
February 6, 2024
How Great Is the Threat of Clonal Hematopoiesis? Let This New Risk Score Be Your Guide
Zhuoer Xie, Amy E DeZern
Hematology. American Society of Hematology. Education Program
|
December 9, 2023
Frontline treatment options for higher-risk MDS: can we move past azacitidine?
David A Sallman, Zhuoer Xie
Stress Biology
|
March 30, 2025
One stone for multiple birds: PigmR integrates multiple defense pathways for high and broad-spectrum blast resistance in rice
Zhuoer Xie, Leiyun Yang, Zhengguang Zhang
Leukemia Research
|
January 29, 2022
Clonal hematopoiesis: Molecular and clinical implications
Yael Kusne, Zhuoer Xie, Mrinal M Patnaik
Clinical Hematology International
|
December 27, 2022
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Carmelo Gurnari, Zhuoer Xie, Amer M Zeidan
Expert Review of Hematology
|
January 31, 2023
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia
Sangeetha Venugopal, Zhuoer Xie, Amer M Zeidan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2026
Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies
Rawan G Faramand, Zhuoer Xie, Michael D Jain
Cancer Journal (Sudbury, Mass.)
|
May 17, 2023
Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment
Jan Philipp Bewersdorf, Zhuoer Xie, Amer M Zeidan
Page
of 9